Industry

Study reveals first-ever structure of a non-viral endogenous reverse transcriptase (eRT) Human endogenous retrovirus-K (HERV-K) RT shows striking similarity to HIV RT Findings enable structure-based drug discovery for eRTs CAMBRIDGE, Mass.–(BUSINESS WIRE)–ROME Therapeutics, a biotechnology company harnessing the power of the dark genome for drug development, today announced a new publication in The Proceedings of … [Read more…]

WIESBADEN, Germany–(BUSINESS WIRE)–The International Centers for Precision Oncology (ICPO) Foundation is pleased to announce that its first Maurits W. Geerlings Next Generation Award presentation for Outstanding Research and Contributions to Actinium-225 Radiopharmaceuticals took place on Friday, June 24 during the 6th TWC in Wiesbaden, Germany (Congress President: Professor Dr. Richard P. Baum). Named after the … [Read more…]

HALIFAX, Nova Scotia–(BUSINESS WIRE)–The union representing the majority of long-term care workers in the province, CUPE Nova Scotia, says that conciliation efforts have failed, and negotiations with the provincial government have reached an impasse. The conciliation officer’s report to the Minister of Labour will be filed on July 8, setting in motion possible job action. … [Read more…]

Backed by top biotech investors, Canaery aims to do for scent what machine vision has done for sight GAINESVILLE, Fla.–(BUSINESS WIRE)–Canaery, the neurotech startup digitizing the sense of smell to enhance the way we perceive and monitor the world around us, announced today it has closed more than $4 million in seed funding to accelerate … [Read more…]

LifeWorks president and CEO speaks about the critical importance of investment in people’s mental health TORONTO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total wellbeing solutions, presented its newest offering at the Corporate Knights 2022 Corporate Citizens Gala, an event honouring Canada’s top corporate citizens. LifeWorks president and chief executive officer, Stephen Liptrap, spoke … [Read more…]

Swoop’s privacy-safe patient segments can now be used by healthcare marketers to plan activation across iHeartMedia’s industry-leading broadcast radio ecosystem. FLORHAM PARK, N.J.–(BUSINESS WIRE)–Swoop, the leader in privacy-safe AI-generated audiences for healthcare marketing, today announced a strategic partnership with iHeartMedia, the leading audio media company in the U.S., that makes its custom patient audiences available … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Critical Care Diagnostics Market Analysis by Type (Coagulation, Haematology, Immunoproteins, Flow Cytometry, Microbial, Infectious Test), by End User (Intensive Care Units, Operating Rooms, Emergency Rooms), and by Region – Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. The global critical care diagnostics market size is estimated to be USD 1.10 billion … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “HER2 Inhibitors Global Market Report 2022: By Treatment, By Application, By End-User” report has been added to ResearchAndMarkets.com’s offering. This report provides strategists, marketers and senior management with the critical information they need to assess the global HER2 inhibitors market. The global her2 inhibitors market is expected to grow from $6.61 billion in … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global Postpartum Hemorrhage Devices Market Size, Share & Industry Trends Analysis Report By Product, By Regional Outlook and Forecast, 2022 – 2028” report has been added to ResearchAndMarkets.com’s offering. The Global Postpartum Hemorrhage (PPH) Devices Market size is expected to reach $1.05 billion by 2028, rising at a market growth of 5.2% CAGR … [Read more…]

Tevogen Bio’s new Research and Development Center is located in Philadelphia’s Wanamaker Office Building Strategic location of the R&D Center compliments Tevogen’s research facility at CIC Philadelphia as the company expands its precision T cell product pipeline in oncology, neurology, and virology WARREN, N.J.–(BUSINESS WIRE)–#Tcells—Tevogen Bio, a late-stage biotechnology company specializing in developing cell and … [Read more…]